Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimizationKunkun Han, Xinliang Mao|Journal of Hematology & Oncology|2014Cited by 80
SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathwayKunkun Han, Xinliang Mao|Scientific Reports|2015Cited by 21